Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov;269(11):5798-5811.
doi: 10.1007/s00415-022-11282-w. Epub 2022 Jul 28.

Influence of heavy metals in Parkinson's disease: an overview

Affiliations
Review

Influence of heavy metals in Parkinson's disease: an overview

Balachandar Vellingiri et al. J Neurol. 2022 Nov.

Abstract

Parkinson's disease (PD) is an ageing disorder with deterioration of dopamine neurons which leads to motor complications like tremor, stiffness, slow movement and postural disturbances. In PD, both genetics as well as environmental factors both play a major role in causing the pathogenesis. Though there are surfeit of risk factors involved in PD occurrence, till now there is lack of an exact causative agent as a risk for PD with confirmative findings. The role of heavy metals reported to be a significant factor in PD pathogenesis. Heavy metal functions in cell maintenance but growing pieces of evidences reported to cause dyshomeostasis with increased PD rate. Metals disturb the molecular processes and results in oxidative stress, DNA damage, mitochondrial dysfunction, and apoptosis. The present review elucidates the role of cobalt, nickel, mercury, chromium, thallium metals in α-synuclein aggregation and its involvement in blood brain barrier flux. Also, the review explains the plausible role of aforementioned metals with a mechanistic approach and therapeutic recommendations in PD.

Keywords: Blood brain barrier; Heavy metals; Parkinson’s disease (PD); Therapeutics; α-synuclein.

PubMed Disclaimer

References

    1. Venkatesan D, Iyer M, Krishnan P et al (2021) A late-onset Parkinson’s disease in tribes in India–a case report. Brain Disord 3:100015 - DOI
    1. Venkatesan D, Iyer M, Narayanasamy A et al (2020) Kynurenine pathway in Parkinson’s disease—an update. Eneurologicalsci 21:100270 - PubMed - PMC - DOI
    1. Venkatesan D, Iyer M, Narayanasamy A et al (2022) Genotypic-phenotypic analysis, metabolic profiling and clinical correlations in Parkinson’s disease patients from Tamil Nadu population, India. J Mol Neurosci. https://doi.org/10.1007/s12031-022-02028-4 - DOI - PubMed
    1. Iyer M, Subramaniam MD, Venkatesan D et al (2021) Role of RhoA-ROCK signaling in Parkinson’s disease. Eur J Pharmacol 894:173815 - PubMed - DOI
    1. Jayaramayya K, Iyer M, Venkatesan D et al (2020) Unraveling correlative roles of dopamine transporter (DAT) and Parkin in Parkinson’s disease (PD): a road to discovery? Brain Res Bull 157:169–179 - PubMed - DOI

LinkOut - more resources